文献速递肝病消化道肿瘤与早癌

β-catenin臂重复5和6致癌突变降低APC结合并增强信号

Oncogenic Mutations in Armadillo Repeats 5 and 6 of β-Catenin Reduce Binding to APC, Increasing Signaling and Transcription of Target Genes.
PubMed 文献 · Gastroenterology · 2019-12-17

该研究探讨β-catenin臂重复5和6的K335I或N387K突变如何增强信号并促进小鼠肝癌发生。小鼠尾静脉注射突变β-catenin与MET质粒后肿瘤更大更晚期;突变体与APC结合亲和力降低但仍与AXIN1及核内TCF7L2互作,导致靶基因转录增加。

要点

  • K335I或N387K β-catenin与MET共注射促进小鼠肝脏肿瘤生长。
  • 突变体通过降低与APC结合增强β-catenin信号。
  • 突变体仍与AXIN1及核内TCF7L2互作,增加靶基因转录。

核心结论

  • β-catenin臂重复5和6的K335I或N387K突变通过降低与APC结合增强信号并促进小鼠肝脏肿瘤形成。

研究设计与样本

  • 将编码带标签全长β-catenin或K335I/N387K突变体及MET的质粒注射入FVB/N小鼠尾部。
  • 在HEK293、HCT116和SNU449细胞中表达带标签全长及突变体β-catenin进行免疫印迹和免疫沉淀分析。
  • 分析一组β-catenin变体及敲入突变细胞系的N端磷酸化、半衰期及信号通路蛋白结合差异。

主要发现

  • 注射K335I或N387K β-catenin与MET质粒的小鼠肿瘤比注射野生型β-catenin与MET质粒的小鼠更大、更晚期。
  • K335I和N387K β-catenin与APC结合亲和力低于野生型,但仍与支架蛋白AXIN1及核内TCF7L2互作。
  • 该互作导致β-catenin调控基因转录增加。
  • 蛋白结构研究支持观察到的相对结合亲和力变化。

临床怎么用

  • 提示β-catenin臂重复5和6突变通过减少APC结合增强信号,可作为肝癌中β-catenin激活的机制解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The β-catenin signaling pathway is one of the most commonly deregulated pathways in cancer cells. Amino acid substitutions within armadillo repeats 5 and 6 (K335, W383, and N387) of β-catenin are found in several tumor types, including liver tumors. We investigated the mechanisms by which these substitutions increase signaling and the effects on liver carcinogenesis in mice. METHODS: Plasmids encoding tagged full-length β-catenin (CTNNB1) or β-catenin with the K335I or N387K substitutions, along with MET, were injected into tails of FVB/N mice. Tumor growth was monitored, and livers were collected and analyzed by histology, immunohistochemistry, and quantitative reverse-transcription polymerase chain reaction. Tagged full-length and mutant forms of β-catenin were expressed in HEK293, HCT116, and SNU449 cells, which were analyzed by immunoblots and immunoprecipitation. A panel of β-catenin variants and cell lines with knock-in mutations were analyzed for differences in N-terminal phosphorylation, half-life, and association with other proteins in the signaling pathway. RESULTS: Mice injected with plasmids encoding K335I or N387K β-catenin and MET developed larger, more advanced tumors than mice injected with plasmids encoding WT β-catenin and MET. K335I and N387K β-catenin bound APC with lower affinity than WT β-catenin but still interacted with scaffold protein AXIN1 and in the nucleus with TCF7L2. This interaction resulted in increased transcription of genes regulated by β-catenin. Studies of protein structures supported the observed changes in relative binding affinities. CONCLUSION: Expression of β-catenin with mutations in armadillo repeats 5 and 6, along with MET, promotes formation of liver tumors in mice. In contrast to N-terminal mutations in β-catenin that directly impair its phosphorylation by GSK3 or binding to BTRC, the K335I or N387K substitutions increase signaling via reduced binding to APC. However, these mutant forms of β-catenin still interact with the TCF family of transcription factors in the nucleus. These findings show how these amino acid substitutions increase β-catenin signaling in cancer cells.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Liu P, Liang B, Liu M, et al. Oncogenic Mutations in Armadillo Repeats 5 and 6 of β-Catenin Reduce Binding to APC, Increasing Signaling and Transcription of Target Genes. Gastroenterology. 2019. PMID: 31857074. doi:10.1053/j.gastro.2019.11.302

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。